Jenburkt Pharmaceuticals Ltd Q1FY25 PAT slips QoQ to Rs. 7.41 crores

JENBURKT PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 33.9414 crores during the period ended June 30, 2024 as compared to Rs. 40.0307 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 7.4160 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 7.8821 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 16.80 for the period ended June 30, 2024 as compared to Rs. 17.86 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 33.9414 crs	₹40.0307 crs	-15.21%
Net Profit	₹7.4160 crs	₹7.8821 crs	-5.91%
EPS	₹16.80	₹17.86	-5.94%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 33.9414 crores during the period ended June 30, 2024 as compared to Rs.30.2124 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.7.4160 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.5.3691 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.16.80 for the period ended June 30, 2024 as compared to Rs.12.17 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 33.9414 crs	₹30.2124 crs	12.34%
Net Profit	₹7.4160 crs	₹5.3691 crs	38.12%
EPS	₹16.80	₹12.17	38.04%

Shares of JENBURKT PHARMACEUTICALS LTD. was last trading in BSE at Rs. 908.40 as compared to the previous close of Rs. 874.55. The total number of shares traded during the day was 12849 in over 389 trades.

The stock hit an intraday high of Rs. 915.00 and intraday low of 880.00. The net turnover during the day was Rs. 11562278.00.

Source : Equity Bulls

Keywords

JenburktPharmaceuticals Q1FY25 FY2025 Q1FY2025 ResultUpdate